CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors
Despite Eli Lilly‘s (NYSE: LLY) dominance in the weight management market, the company has encountered several obstacles in this field, including spotty insurance coverage for its anti-obesity medicine, Zepbound. If Eli Lilly could make headway in that area, it could boost the already fast-growing sales of this medicine. That’s why recent news from CVS Health…
